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See related research by Wu et al., http://www.ccforum.com/content/19/1/310Wu and colleagues retrospectively analyzed the clinical
data of 541 patients who were diagnosed with Guillain-
Barré syndrome (GBS) from 2003 to 2014, among whom
80 patients (14.8 %) required mechanical ventilation [1].
Via multivariate logistic regression analysis, independent
predictors for mechanical ventilation and short-term
prognosis in mechanically ventilated patients were iden-
tified [1]. This study was well designed and conducted.
In-hospital infections were not mentioned in the study,
however, which seems lacking for such a study given it is
an important parameter.
We wonder whether the rate of in-hospital infections was
simply not included in the analysis or whether it was
proved not to be an independent predictor for mechanical
ventilation after multivariate logistic regression analysis. Ali
and colleagues [2] described a historical cohort of mechan-
ically ventilated patients with GBS in a tertiary-care center.* Correspondence: anny_069@163.com
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(http://creativecommons.org/publicdomain/zeThey found that ventilator-associated pneumonia was the
most frequent complication and was associated with pro-
longed mechanical ventilation [2]. We are eager, therefore,
to know about the incidence of ventilator-associated pneu-
monia and whether it is a predictor for poor short-term
outcome. In addition, intravenous corticosteroids are not
recommended for the treatment of GBS according to sev-
eral international guidelines and we would like to know
why corticosteroids were used on a large number of pa-
tients with GBS in the study by Wu and colleagues.
GBS typically occurs after an infectious disease, two-
thirds of patients presenting with symptoms of a respiratory
or gastrointestinal tract infection before its onset [3]. Wu
and colleagues included antecedent infections as a param-
eter in their analysis; however, we are eager to know
whether stratified analysis according to respiratory and
gastrointestinal infections was performed.We appreciate Yang and Jia’s comments on our study. As
they mentioned, GBS is usually triggered by antecedent
infections. In the retrospective study, however, stratified
analysis was not performed to address whether different
antecedent infections could serve as a predictor for mech-
anical ventilation and short-term prognosis. The overall
incidence of in-hospital infections for the patients with
GBS was approximately 19.6 % in our study. The inci-
dence was 85.8 % in mechanically ventilated patients,
most of which were ascribed to ventilator-associated
pneumonia, and was significantly lower in those without
respiratory assistance (11.4 %, P < 0.01). Thus, we did not
include in-hospital infections in predicting mechanical
ventilation due to their inherent causal relationship. Thiswas also the case when we searched for predictors for
short-term prognosis of patients who required mechanical
ventilation. However, the poor short-term prognosis of
mechanically ventilated patients might be related to
ventilator-associated pneumonia, which may potentially
increase the duration of mechanical ventilation [4].
As to the therapeutic values of corticosteroids in treat-
ing GBS, they were proved ineffective when administered
alone [5]. Nevertheless, a study found that 76 % of patients
who received intravenous immunoglobulin (IVIg) com-
bined with corticosteroids improved by at least one grade
on the GBS disability scale compared with 53 % patients
in the IVIg-treated group [6]. The median time to regain
unaided walking was also shorter in the combination
therapy group [6]. Similar results were found when ad-
justments were made in a randomized double-blind,
placebo-controlled and multicentre study [7]. Thus,e is distributed under the terms of the Creative Commons Attribution 4.0
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Yang and Jia Critical Care  (2015) 19:407 Page 2 of 2intravenous corticosteroids as an add-on therapy have
been used in the treatment of severe or protracted GBS
cases [7]. However, we found that add-on use of intraven-
ous corticosteroids was a risk factor for poor short-term
prognosis in mechanically ventilated patients who were
severely paralyzed. This might either be due to its harmful
effects on denervated muscles or its inhibition of macro-
phage functions in the reparative and regenerative pro-
cesses of the peripheral nerves [8] or be related to the
increased incidence of in-hospital infections and hypergly-
cemia caused by intravenous use of corticosteroids [4, 5].
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